JVMCX
Price
$27.01
Change
+$0.05 (+0.19%)
Updated
Aug 8 closing price
Net Assets
23.18B
PMVEX
Price
$25.37
Change
+$0.08 (+0.32%)
Updated
Aug 8 closing price
Net Assets
160.1M
Interact to see
Advertisement

JVMCX vs PMVEX

Header iconJVMCX vs PMVEX Comparison
Open Charts JVMCX vs PMVEXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$27.01
Change+$0.05 (+0.19%)
VolumeN/A
Net Assets23.18B
PGIM Quant Solutions Mid-Cap Val R2
Price$25.37
Change+$0.08 (+0.32%)
VolumeN/A
Net Assets160.1M
JVMCX vs PMVEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVMCX vs. PMVEX commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Buy and PMVEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 23.2B vs. PMVEX (160M). PMVEX pays higher dividends than JVMCX: PMVEX (1.29) vs JVMCX (0.00). JVMCX was incepted earlier than PMVEX: JVMCX (14 years) vs PMVEX (8 years). PMVEX (25.08) is less costly to investors than JVMCX (1.88). PMVEX is a more actively managed with annual turnover of: 97.00 vs. JVMCX (49.00). PMVEX has a lower initial minimum investment than JVMCX: PMVEX (0) vs JVMCX (1000). PMVEX annual gain was more profitable for investors over the last year : 8.14 vs. JVMCX (0.07). PMVEX return over 5 years is better than : 89.62 vs. JVMCX (43.66).
JVMCXPMVEXJVMCX / PMVEX
Total Expense Ratio1.871.23152%
Annual Report Gross Expense Ratio1.8825.087%
Fund Existence14 years8 years-
Gain YTD6.5612.847230%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.2B160M14,500%
Annual Yield % from dividends0.001.29-
Returns for 1 year0.078.141%
Returns for 3 years12.0221.0957%
Returns for 5 years43.6689.6249%
Returns for 10 years31.85N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIFYX32.55N/A
N/A
Victory RS Science and Technology Y
VHGEX40.31N/A
N/A
Vanguard Global Equity Inv
HCMIX31.92N/A
N/A
HCM Tactical Plus I
ARAHX6.61N/A
N/A
Aristotle Small/Mid Cap Equity A
DSMFX13.68-0.01
-0.07%
Destinations Small-Mid Cap Equity I